Modelled DT Structure
Method: homology modeling
Template PDB: 2LCK_A
Identity: 73.09%
Minimized Score: -467.227 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0226 | ||||
| Gene Name | SLC25A9 | ||||
| Protein Name | Mitochondrial uncoupling protein 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 2LCK_A Identity: 73.09% Minimized Score: -467.227 kcal/mol Detail: Structure Info |
||||
| Synonyms | SLC25A9; Solute carrier family 25 member 9; UCP 3; UCP3 | ||||
| DT Family | Mitochondrial Carrier (MC) Family ; | ||||
| Tissue Specificity | Only in skeletal muscle and heart. Is moreexpressed in glycolytic than in oxidative skeletal muscles. | ||||
| Function | This transporter is mitochondrial transporter proteins that create proton leaks across the inner mitochondrial membrane, thus uncoupling oxidative phosphorylation. As a result, energy is dissipated in the form of heat. It may play a role in the modulation of tissue respiratory control. It participates in thermogenesis and energy balance. | ||||
| Endogenous Substrate(s) | H+; Cl- | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.